Last reviewed · How we verify

NCT05502679

Immediate Versus Late Weight Bearing After Tibial Plateau Fractures Internal Fixation

Completed NA Last updated 20 August 2024
What this trial tests

NA trial testing Weight bearing as tolerated in Fracture of Tibia Proximal Plateau in 56 participants. Completed in 20 July 2024.

Timeline
1 September 2022
Primary endpoint
1 June 2024
20 July 2024

Quick facts

Lead sponsorAssiut University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment56
Start date1 September 2022
Primary completion1 June 2024
Estimated completion20 July 2024
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Assiut University

Who can join

Adults 18 to 65, any sex, with Fracture of Tibia Proximal Plateau. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Postoperative rehabilitation for tibial plateau fracture generally involves prolonged non-weight bearing time while other protocols use partial weight-bearing and bracing before full weight-bearing is recommended at 9 to 12 weeks following surgical fixation. No study to date has investigated the effect of standardized pragmatic exercise protocol added to immediate weight bearing after tibial plateau fractures surgical fixation on patient's functional outcomes, knee ROM, pain, radiographic boney alignment, gait, and return to work.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Weight bearing as tolerated

Trials testing the same drug.

Other Assiut University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05502679.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing